Press release
Celiac Disease Treatment Market to Reach USD 2.65 Billion by 2034
Celiac Disease Treatment
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/49858
Celiac disease - an autoimmune disorder triggered by gluten consumption - is gaining increased global attention due to enhanced serological testing, HLA genotyping, and rising adoption of gluten-free therapeutics among patients and healthcare providers.
Key Takeaways
• Market Size: USD 1.56 billion (2024) → USD 2.65 billion (2034)
• CAGR: 5.6 % (2025-2034)
• Dominant Therapy: Gluten-free diet management remains standard care
• Emerging Treatment: Enzyme therapy and gluten-degrading drugs
• Leading Regions: North America dominates; Europe and Asia-Pacific showing rapid growth
Market Story
Celiac disease affects millions globally, with rising incidence driven by improved diagnostic screening and awareness of gluten intolerance.
Traditionally managed through a strict lifelong gluten-free diet, treatment paradigms are expanding toward pharmaceutical interventions aimed at restoring gut integrity and immune regulation.
Innovative therapies under development include enzyme-based gluten degradation drugs, tight-junction modulators, and immune tolerance therapies. These are designed to supplement dietary management and reduce the inflammatory response caused by gluten exposure.
Companies are focusing on oral formulations that break down gluten peptides before they reach the small intestine, while diagnostic advancements are improving early detection through biomarker testing and next-generation serology.
The rise of digital health apps and gluten-tracking platforms has also improved patient compliance, supporting better disease management and long-term outcomes.
Segmentation Overview
By Drug Type
• Enzyme Therapy
• Tight Junction Modulators
• Immune Modulators
• Gluten Absorption Blockers
• Others
By Treatment Type
• Pharmaceutical Therapy
• Gluten-Free Diet & Nutritional Management
By Route of Administration
• Oral
• Injectable
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa
Explore Full Report here: https://exactitudeconsultancy.com/reports/49858/celiac-disease-treatment-market
Recent Developments
• Takeda Pharmaceutical Company advanced its TAK-062 enzyme therapy candidate into clinical trials, showing promise in gluten degradation.
• 9 Meters Biopharma continued development of larazotide acetate, a tight junction regulator targeting intestinal permeability.
• ImmunogenX Inc. progressed Latiglutenase (IMGX003) through Phase 2 trials, aimed at mitigating gluten-induced immune activation.
• Innovate Biopharmaceuticals and Anokion SA announced new pipeline collaborations for immune tolerance therapies.
• Nestlé Health Science expanded its gluten-free nutritional portfolio to support dietary management in mild to moderate celiac cases.
Expert Quote
"Celiac disease treatment is transitioning from dietary management to precision therapeutics.
Enzyme-based and immune-modulating therapies are redefining the future of gluten intolerance care,"
said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49858
Market Drivers
• Rising global diagnosis and awareness rates for gluten-related disorders
• Ongoing pharmaceutical innovation in enzyme and immune therapy
• Expansion of gluten-free food and nutraceutical markets
• Technological advances in genetic and serological testing
• Government support and NGO awareness programs promoting early detection
Forecast and Outlook
Between 2025 and 2034, the celiac disease market will evolve beyond gluten avoidance toward targeted medical solutions.
Pharmaceutical pipelines are expected to introduce adjunctive therapies that allow dietary flexibility and reduce intestinal inflammation.
Digital monitoring tools, patient education platforms, and AI-assisted dietary management will further enhance treatment adherence and outcome tracking.
Asia-Pacific and Europe are anticipated to experience rapid market growth due to increasing patient diagnosis rates and gluten-free lifestyle adoption.
Regional Insights
• North America: Largest market; strong presence of clinical trials and gluten-free food manufacturers.
• Europe: Rising demand for advanced enzyme therapies and regulated gluten-free labeling systems.
• Asia-Pacific: Fastest-growing region, driven by urbanization and awareness of autoimmune conditions.
• Latin America: Expanding diagnosis base supported by nutrition-focused healthcare programs.
• Middle East & Africa: Gradual adoption of gluten-free dietary practices and diagnostic accessibility improvements.
Conclusion
The Global Celiac Disease Treatment Market is entering a new era of medical and technological innovation.
While dietary management remains foundational, enzyme therapy, gut-protective drugs, and immune regulation treatments are paving the way for comprehensive disease control.
Companies that integrate pharma innovation, diagnostics, and patient-centric digital solutions will lead the market's next growth phase.
This report is also available in the following languages : Japanese (セリアック病治療市場), Korean (셀리악병 치료 시장), Chinese (乳糜泻治疗市场), French (Marché des traitements contre la maladie cœliaque), German (Markt für Zöliakie-Behandlungen), and Italian (Mercato del trattamento della celiachia), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49858#request-a-sample
Related Reports
Malabsorption Syndrome Market
https://exactitudeconsultancy.com/reports/51970/malabsorption-syndrome-market
Transglutaminase IgA ELISA Test Kit Market
https://exactitudeconsultancy.com/reports/65900/transglutaminase-iga-elisa-test-kit-market
Celiac Disease Testing Market
https://exactitudeconsultancy.com/reports/66017/celiac-disease-testing-market
Celiac Disease Market
https://exactitudeconsultancy.com/reports/71310/celiac-disease-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Celiac Disease Treatment Market to Reach USD 2.65 Billion by 2034 here
News-ID: 4263669 • Views: …
More Releases from Exactitude Consultancy
Home Medical Equipment Market to Reach USD 59.8 Billion by 2034
The Global Home Medical Equipment Market is witnessing strong expansion as healthcare shifts toward home-based care, fueled by an aging population, chronic disease burden, and increasing patient preference for remote health management. According to Exactitude Consultancy, the market, valued at USD 35.6 billion in 2024, is projected to reach USD 59.8 billion by 2034, growing at a CAGR of 5.4 % during 2025-2034.
Download Full PDF Sample Copy of Market Report…
Paranasal Sinus Cancer Market to Reach USD 2.1 Billion by 2034
Pune, India, November 11, 2025 - The global Paranasal Sinus Cancer Market is expected to expand from USD 1.2 billion in 2024 to USD 2.1 billion by 2034, registering a CAGR of 5.8%, according to Exactitude Consultancy. The rising incidence of head and neck cancers, improvements in diagnostic imaging, and increased adoption of targeted immunotherapies are driving global market growth.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/49136
Key Takeaways
• Market…
Clear Aligners Market to Reach USD 27.6 Billion by 2034
The Global Clear Aligners Market is expanding rapidly as consumers and dental professionals increasingly prefer invisible orthodontic solutions over traditional braces. According to Exactitude Consultancy, the market, valued at USD 7.5 billion in 2024, is projected to reach USD 27.6 billion by 2034, growing at a remarkable CAGR of 13.7 % from 2025 to 2034.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/49167
Rising aesthetic consciousness, technological advances in dental…
Facial Injectors Market to Reach USD 29.7 Billion by 2034
The Global Facial Injectors Market continues to experience robust growth as aesthetic treatments become more mainstream and technology improves precision, safety, and patient outcomes. According to Exactitude Consultancy, the market, valued at USD 15.8 billion in 2024, is projected to reach USD 29.7 billion by 2034, growing at a CAGR of 6.5 % from 2025 to 2034.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/49162
Increasing consumer demand for non-surgical…
More Releases for Celiac
Celiac Disease Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Celiac Disease Market Size, Share & Trends Analysis Report By Treatments (Infliximab, Larazotide Acetate, Gluten Free Diet), Route Of Administration (Oral And Parenteral), End-Users (Hospitals, Homecare), And Distribution Channels (Hospital Pharmacy, Online Pharmacy, And Retail Pharmacy), Region, Market Outlook And Industry Analysis 2031"
The Global Celiac Disease Market is estimated to reach over USD 1,195.5 Mn…
Celiac Disease Market Emerging Trends and Growth Prospects 2034
Introduction
Celiac disease is a chronic autoimmune disorder triggered by gluten ingestion in genetically susceptible individuals, leading to intestinal damage, malabsorption, and systemic complications. Affecting approximately 1% of the global population, the disease remains underdiagnosed, with many patients suffering from undiagnosed or mismanaged symptoms such as abdominal pain, diarrhea, anemia, osteoporosis, and neurological issues.
The cornerstone of treatment for decades has been the lifelong gluten-free diet (GFD), which requires strict avoidance of…
Celiac Disease Market Revenue Report with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Celiac Disease Market Size, Share & Trends Analysis Report By Treatments (Infliximab, Larazotide Acetate, Gluten Free Diet), Route Of Administration (Oral And Parenteral), End-Users (Hospitals, Homecare), And Distribution Channels (Hospital Pharmacy, Online Pharmacy, And Retail Pharmacy), Region, Market Outlook And Industry Analysis 2031"
The Global Celiac Disease Market is estimated to reach over USD 1,195.5 Mn…
Celiac Disease Treatment Market
Celiac disease is an autoimmune disorder that affects the small intestine, triggered by the ingestion of gluten-a protein found in wheat, barley, and rye. This condition leads to inflammation and damage in the intestinal lining, which can hinder nutrient absorption and result in various gastrointestinal and systemic symptoms. As awareness of celiac disease grows, so does the demand for effective treatments and dietary solutions. This post delves into the celiac…
Celiac Disease Drugs Market to Record an Exponential CAGR
Celiac Disease Drugs Market report analyses the prospects in the market for several shareholders and aspirants by identifying the high-growth segments, main actions approved by them and Celiac Disease Drugs market recent progressions. The Celiac Disease Drugs market report is prepared after fundamental levels of research regarding the Celiac Disease Drugs Industry.
Celiac Disease Drugs Market by Drugs (First Line of Treatment and Second Line of Treatment) - Global Opportunity Analysis…
Celiac disease market: Global Trends and Forecast Analysis 2025
Celiac disease is an autoimmune disorder in which the surface of the small intestine is damaged by a protein called gluten. Gluten is found in rye, barley, and wheat. Gluten triggers an immune reaction in the small intestine damaging the villi (small finger-like projections in the small intestine which promote absorption). The damage restricts the ability of the body to absorb proteins, nutrients, fats, vitamins, carbohydrates, and minerals. Eventually, this…
